EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis

被引：17

作者：

Palacios, Santiago ^{[1
]}

Brincat, Mark

Erel, C. Tamer ^{[2
]}

Gambacciani, Marco ^{[3
]}

Lambrinoudaki, Irene ^{[4
]}

Moen, Mette H. ^{[5
,6
]}

Schenck-Gustafsson, Karin ^{[7
,8
,9
]}

Tremollieres, Florence ^{[10
]}

Vujovic, Svetlana ^{[11
]}

Rees, Margaret ^{[12
]}

Rozenberg, Serge ^{[13
]}

机构：

[1] Palacios Inst Womans Hlth Antonio Acuna, Madrid 28009, Spain

[2] Istanbul Univ, Dept Obstet & Gynecol, Cerrahpasa Med Sch, TR-34365 Istanbul, Turkey

[3] Univ Pisa, Dept Obstet & Gynecol, I-56100 Pisa, Italy

[4] Univ Athens, Dept Obstet & Gynecol 2, Aretaieio Hosp, GR-11528 Athens, Greece

[5] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, NO-7491 Trondheim, Norway

[6] Univ Trondheim Hosp, St Olavs Hosp, Dept Obstet & Gynecol, NO-7006 Trondheim, Norway

[7] Karolinska Inst, Dept Med, Cardiol Unit, SE-17176 Stockholm, Sweden

[8] Karolinska Inst, Head Ctr Gender Med, SE-17176 Stockholm, Sweden

[9] Karolinska Univ Hosp, SE-17176 Stockholm, Sweden

[10] Hop Paule de Viguier, Menopause & Metab Bone Dis Unit, F-31059 Toulouse 09, France

[11] Belgrade Sch Med, Clin Ctr Serbia, Inst Endocrinol, Beograd 11000, Serbia

[12] John Radcliffe Hosp, Womens Ctr, Oxford OX3 9DU, England

[13] Univ Libre Bruxelles, CHU St Pierre, Dept Obstet & Gynecol, B-1000 Brussels, Belgium

来源：

MATURITAS | 2012年 / 71卷 / 02期

关键词：

Postmenopausal osteoporosis; Selective estrogen receptor modulators; Bazedoxifene; Lasofoxifene; Raloxifene; Tamoxifen; SURGICAL ADJUVANT BREAST; BAZEDOXIFENE/CONJUGATED ESTROGENS; BOWEL PROJECT; CONTROLLED PHASE-3; DOUBLE-BLIND; CANCER; WOMEN; RALOXIFENE; TAMOXIFEN; PLACEBO;

D O I：

10.1016/j.maturitas.2011.11.010

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：194 / 198

页数：5

共 50 条

[21] Clinical use of selective estrogen receptor modulators
Fontana, A
Delmas, PD
CURRENT OPINION IN RHEUMATOLOGY, 2001, 13 (04) : 333 - 339
[22] Clinical pharmacology of selective estrogen receptor modulators
Haynes, B
Dowsett, M
DRUGS & AGING, 1999, 14 (05) : 323 - 336
[23] Raloxifene: The first selective estrogen receptor modulator for postmenopausal osteoporosis
不详
Drugs & Therapy Perspectives, 1998, 12 (7) : 1 - 5
[24] Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis
de Villiers, T. J.
CLIMACTERIC, 2010, 13 (03) : 210 - 218
[25] Risk of Venous Thromboembolism with Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Trials
Dhital, Rashmi
Poudel, Dilli
Timilsina, Bidhya
Lynn, Theresa
Peters, Colin
Oladiran, Oreoluwa
Parajuli, Prem
Paudel, Prakash
Donato, Anthony
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[26] Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis
Komm, Barry S.
Chines, Arkadi A.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (01) : 21 - 34
[27] Selective estrogen receptor modulators and phytoestrogens: New therapies for the postmenopausal woman
Fitzpatrick, LA
MAYO CLINIC PROCEEDINGS, 1999, 74 (06) : 601 - 607
[28] Selective estrogen receptor modulators: A controversial approach for managing postmenopausal health
Curtis, MG
JOURNAL OF WOMENS HEALTH, 1999, 8 (03) : 321 - 333
[29] Treatment of Osteoporosis Selective Estrogen Receptor Modulators (SERMs) and new Options
Hadji, P.
Lippuner, K.
Concin, H.
Scharla, S.
Birkhaeuser, M.
Fahrleitner-Pammer, A.
Finkenstedt, G.
Jakob, F. J.
Schwarz, H.
Stute, P.
Ziller, V.
OSTEOLOGIE, 2010, 19 (04) : 384 - 391
[30] Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males
Kastelan, Darko
Giljevic, Zlatko
Kraljevic, Ivana
Korsic, Mirko
MEDICAL HYPOTHESES, 2006, 67 (05) : 1052 - 1053

← 1 2 3 4 5 →